Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleolar protein 14 (NOP14) is a highly conserved nucleolar protein involved primarily in the nucleolar processing of pre-18S ribosomal RNA and the nuclear export of the 40S pre-ribosomal subunit to the cytoplasm[1][2][6][7]. It plays an essential role in ribosome biogenesis, and has been implicated in regulating cell proliferation and migration, particularly in pancreatic cancer[2]. Alternative splicing results in multiple transcript variants. Although mutations or dysregulation of NOP14 are associated with certain genetic syndromes, such as Bowen-Conradi syndrome, it is not classified as a conventional therapeutic target such as an enzyme, receptor, ion channel, or transporter[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleolar protein 14 (NOP14).